Prescription drug · ANDA
Carbamazepine NDC 67046-0707
Carbamazepine 200 mg/1 · Tablet · Oral · Coupler LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 67046-0707-3 | 67046070703 | 30 TABLET in 1 BLISTER PACK (67046-0707-3)Marketed from Jun 15, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Carbamazepine
- Generic name (nonproprietary)
- carbamazepine
- Active ingredients
- Carbamazepine — 200 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Coupler LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207798
- Marketing start
- Listing expires
- Other FDA classes
- Cytochrome P450 1A2 Inducers (Mechanism)Cytochrome P450 2B6 Inducers (Mechanism)Cytochrome P450 2C19 Inducers (Mechanism)Cytochrome P450 2C9 Inducers (Mechanism)Cytochrome P450 3A4 Inducers (Mechanism)Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
- Identifiers
- Product ID 67046-0707_544e41b1-cf88-ae63-e063-6394a90ac69bSPL ID 544e41b1-cf88-ae63-e063-6394a90ac69bSPL set ID 544e3b55-c8a3-a480-e063-6394a90abbb5RxCUI 308979UNII 33CM23913M
- Pharmacologic class
- Mood Stabilizer
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N467046070703followed by a unit qualifier and the quantityPackage 67046-0707-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Epilepsy Carbamazepine is indicated for use as an anticonvulsant drug. Evidence supporting efficacy of carbamazepine as an anticonvulsant was derived from active drug-controlled studies that enrolled patients with the following seizure types: 1. Partial seizures with complex symptomatology (psychomotor, temporal lobe). Patients with these seizures appear to show greater improvement than those with other types. 2. Generalized tonic-clonic seizures (grand mal). 3. Mixed seizure patterns which include the above, or other partial or generalized seizures. Absence seizures (petit mal) do not appear to be controlled by carbamazepine (see PRECAUTIONS , General). Trigeminal Neur…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 207798
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Carbamazepine | Carbamazepine 100 mg/1 | TabletOral | NIVAGEN PHARMACEUTICALS, INC. | 75834-220 |
| Carbamazepine | Carbamazepine 200 mg/1 | TabletOral | NIVAGEN PHARMACEUTICALS, INC. | 75834-221 |
| Carbamazepine | Carbamazepine 200 mg/1 | TabletOral | direct rx | 72189-157 |
| Carbamazepine | Carbamazepine 200 mg/1 | TabletOral | A-S Medication Solutions | 50090-5740 |
| Carbamazepine | Carbamazepine 200 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-7825 |
| Carbamazepine | Carbamazepine 200 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-1730 |
| Carbamazepine | Carbamazepine 200 mg/1 | TabletOral | Umedica Laboratories USA Inc. | 60290-008 |
| Carbamazepine | Carbamazepine 200 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-2841 |
| Carbamazepine | Carbamazepine 100 mg/1 | TabletOral | Umedica Laboratories USA Inc. | 60290-034 |